ECSP992942A - HEMATOPOYETIC STIMULATION - Google Patents

HEMATOPOYETIC STIMULATION

Info

Publication number
ECSP992942A
ECSP992942A ECSP992942A ECSP992942A EC SP992942 A ECSP992942 A EC SP992942A EC SP992942 A ECSP992942 A EC SP992942A EC SP992942 A ECSP992942 A EC SP992942A
Authority
EC
Ecuador
Prior art keywords
hematopoietic cells
stimulation
products
methods
hydroxyl group
Prior art date
Application number
Other languages
Spanish (es)
Inventor
Barbara P Wallner
Barry Jones
Glenn Miller
Sharlene Adams
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to ECSP992942 priority Critical patent/ECSP992942A/en
Publication of ECSP992942A publication Critical patent/ECSP992942A/en

Links

Landscapes

  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Se proporcionan métodos y productos para la estimulación de células hematopoyéticas, para la prevención de bajos niveles de células hematopoyéticas, y las producción de incrementos números de células hematopoyéticas y células sanguineas maduras. Los métodos y productos se pueden usar tanto in vitro. Los agentes útiles de acuerdo con la invención son compuestos de fórmula I: (gráfico), en donde m es un entero entre 0 y 10, inclusive; A y A1 son residuos Laminoácidos (para glicina no hay dicha distinción), de manera que el A en cada unidad de repetición entre paréntesis puede ser un residuo de aminoácido diferente; el C enlazado a B se encuentra en la configuración L; los enlaces entre A y N A1 y C y entre péptidos; y cada X1 y X2 es independientemente, un grupo hidroxilo o un grupo capaz de ser hidrolizado a un grupo hidroxilo en solución acuosa a pH fisiológico.Methods and products are provided for the stimulation of hematopoietic cells, for the prevention of low levels of hematopoietic cells, and the production of increased numbers of hematopoietic cells and mature blood cells. The methods and products can be used both in vitro. Agents useful in accordance with the invention are compounds of formula I: (graph), wherein m is an integer from 0 to 10, inclusive; A and A1 are Lamino Acid residues (for glycine there is no such distinction), so that A in each repeat unit in parentheses may be a different amino acid residue; C linked to B is in configuration L; the bonds between A and N A1 and C and between peptides; and each X1 and X2 is independently a hydroxyl group or a group capable of being hydrolyzed to a hydroxyl group in aqueous solution at physiological pH.

ECSP992942 1999-05-04 1999-05-04 HEMATOPOYETIC STIMULATION ECSP992942A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ECSP992942 ECSP992942A (en) 1999-05-04 1999-05-04 HEMATOPOYETIC STIMULATION

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ECSP992942 ECSP992942A (en) 1999-05-04 1999-05-04 HEMATOPOYETIC STIMULATION

Publications (1)

Publication Number Publication Date
ECSP992942A true ECSP992942A (en) 1999-07-08

Family

ID=42043932

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSP992942 ECSP992942A (en) 1999-05-04 1999-05-04 HEMATOPOYETIC STIMULATION

Country Status (1)

Country Link
EC (1) ECSP992942A (en)

Similar Documents

Publication Publication Date Title
MY132924A (en) Hematopoietic stimulation
ES2189423T3 (en) BOROPROLINE CYCLING COMPOUNDS.
TR200401142T4 (en) Process for dissolving glucagon-like peptide compounds.
BG103335A (en) Application of fumaric acid derivatives
CO5580776A2 (en) STABLE PHARMACEUTICAL FORMULATION IN SOLUTION OF OXALIPLATIN
PT923570E (en) AMIDES OF PYRIDYL-ALCENOIC AND PYRIDYL-ALCINIC ACIDS AS CITOSTATIC AND IMMUNOSUPRESSIVE AGENTS
ATE54154T1 (en) RETRO-INVERSE ANALOGS OF BRADYKIN POTENTIALIZING PEPTIDE BPP-5A AND METHODS FOR THEIR PRODUCTION.
DE69532760D1 (en) AGENTS FOR THE ADMINISTRATION OF ANTIGENS
TR199901949T2 (en) From lymphosis to t�m�rler i�in �areler.
HUP9802206A1 (en) Intravenous thaidomid composition for treating immunological diseases
ES2184302T3 (en) PROCEDURE FOR PREPARATION OF THE ACID 1,4,7,10-TETRAAZACICLODODECANO-1,4,7-TRIACETICO AND DERIVATIVES OF THE SAME.
DK482185A (en) PEPTIDES, THEIR PREPARATION AND USE AS MEDICINES
AR033979A1 (en) METHOD FOR PREPARING A PHYSIOLOGICALLY ACTIVE POLYPEPTIDE
FI971949A0 (en) Storage-resistant aqueous solution containing thrombin inhibitor for infusion
ECSP992942A (en) HEMATOPOYETIC STIMULATION
AU6011001A (en) Novel lhrh-antagonists, production and use thereof as medicament
IT1320782B1 (en) COMPOSITIONS BASED ON AMINO ACIDS, SUITABLE FOR THE TREATMENT OF HEART INSUFFICIENCY.
AR020052A1 (en) FERRO-SUCCINYLCASEINE OBTAINED FROM THE FOOD CASEINE, PROCEDURE FOR THE PREPARATION, PHARMACEUTICAL COMPOSITIONS CONTAINING IT, AND SUBSIDY IN THE TREATMENT OF PATHOLOGICAL STATES DERIVED BY THE LACK OF IRON
ES2056149T3 (en) AMBLIOMMINA, A NEW ACTIVE SUBSTANCE FOR ANTICOAGULANT THERAPY.
ATE25708T1 (en) BIOLOGICALLY ACTIVE CONJUGATES, THEIR PRODUCTION AND USE.
SE8700016D0 (en) GONADOLIBERIN DERIVATIVES CONTAINING AND AROMATIC AMINOCARBOXYLIC ACID IN THE 6-POSITION, PHARMACEUTICAL AND VETERINARY COMPOSITIONS CONTAINING THEM AND PROCESS FOR PREPARING SAME
DK1019037T3 (en) Drug containing delta-aminolevulinic acid
PE43995A1 (en) PROCEDURE FOR THE PREVENTION OF THE DEGRADATION OF PROTEIN C
ES478204A1 (en) Psychopharmacological peptides, process for their preparation and their pharmaceutical formulations.
IT1250653B (en) FIBRINOLYTIC ENZYMES AMID AND THEIR PRECURSORS, AND PROCESSES FOR THEIR PREPARATION.